Gasco, Florenda M.
HRN: 21-37-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2022
CEFUROXIME 500MG (TAB)
05/28/2022
06/04/2022
PO
500mg
BID
S/P TAHBSO Prophylaxis
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes